Tasosartan
CAS No. 145733-36-4
Tasosartan( WAY-ANA 756 )
Catalog No. M21071 CAS No. 145733-36-4
Tasosartan is an antagonist of angiotensin II type 2 (AT2) receptor (IC50 = 1.2 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 67 | Get Quote |
|
| 5MG | 110 | Get Quote |
|
| 10MG | 177 | Get Quote |
|
| 25MG | 300 | Get Quote |
|
| 50MG | 447 | Get Quote |
|
| 100MG | 624 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTasosartan
-
NoteResearch use only, not for human use.
-
Brief DescriptionTasosartan is an antagonist of angiotensin II type 2 (AT2) receptor (IC50 = 1.2 nM).
-
DescriptionTasosartan is an antagonist of angiotensin II type 2 (AT2) receptor (IC50 = 1.2 nM).
-
In VitroTasosartan is an orally active nonpeptide AngII antagonist that has demonstrates specific and selective AT1 receptor antagonistic activity in vitro.IC50 for inhibition of specific binding of 125I-AngII to rat adrenal membrane in the absence of proteins in binding buffer is 1.2±0.6 nM.
-
In VivoAdministration of Tasosartan at doses of 1.0 and 3.0 mg/kg (iv) significantly (p<0.05) attenuates the pressor response to angiotensin-II in rats.
-
SynonymsWAY-ANA 756
-
PathwayEndocrinology/Hormones
-
TargetRAAS
-
RecptorAT2 receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number145733-36-4
-
Formula Weight411.46
-
Molecular FormulaC23H21N7O
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL (303.80 mM)
-
SMILESCc1nc(C)c2c(n1)N(Cc1ccc(-c3ccccc3-c3nn[nH]n3)cc1)C(=O)CC2
-
Chemical Name8-((2'-(1H-tetrazol-5-yl)-[11'-biphenyl]-4-yl)methyl)-24-dimethyl-58-dihydropyrido[23-d]pyrimidin-7(6H)-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Maillard M P Rossat J Brunner H R et al. Tasosartan enoltasosartan and angiotensin II receptor blockade: The confounding role of protein binding[J]. Journal of Pharmacology & Experimental Therapeutics 2000 295(2):649-654.
molnova catalog
related products
-
Breviscapin
Breviscapine is the total flavonoid components (the content of scutellarin > or =85%) extracted from the dried whole plant of Erigeron breviscapus.
-
Ramiprilat
Ramiprilat is an angiotensin-converting enzyme (ACE) inhibitor?with antihypertensive activity.
-
ANGIOTENSIN IV TFA
ANGIOTENSIN IV TFA is a less effective agonist at the angiotensin AT1 receptor.
Cart
sales@molnova.com